The oxycodone market is set for significant growth, with projections indicating a rise from US$ 5.11 billion in 2023 to over US$ 8.92 billion by 2033. This marks a substantial increase, with a compound annual growth rate (CAGR) of 5.7% expected between 2023 and 2033. The growth is primarily driven by the escalating demand for efficient pain management remedies, as oxycodone remains a widely prescribed medication for severe pain relief.
Oxycodone, a potent opioid, has played a central role in the broader opioid market, helping millions of patients manage chronic and post-surgical pain. However, concerns surrounding misuse, addiction, and the opioid crisis have prompted greater regulatory scrutiny. In response, prescribing practices have evolved, with healthcare professionals emphasizing responsible opioid use, which has influenced the market dynamics. These regulatory interventions aim to balance pain management needs with efforts to combat opioid abuse.
Despite challenges related to safety concerns and policy changes, the oxycodone market continues to experience growth as patients seek effective solutions for pain relief. The development of alternative formulations and responsible prescribing guidelines will continue to shape the market’s future trajectory.
Grab Your Complete Report Instantly – https://www.futuremarketinsights.com/reports/oxycodone-market
Key Highlights:
- The oxycodone market is expected to grow from US$ 5.11 billion in 2023 to over US$ 8.92 billion by 2033.
- The market will grow at a CAGR of 5.7% during the forecast period.
- The growth is driven by rising demand for pain management solutions despite concerns over opioid misuse.
- Regulatory changes and evolving prescribing practices are impacting market dynamics.
As the oxycodone market expands, the industry will need to navigate the challenges of opioid safety while continuing to meet the growing need for effective pain management solutions.
Growth Drivers
- Rising Demand for Pain Management: The increasing need for effective pain management solutions is a primary driver of oxycodone sales, particularly as chronic pain becomes more prevalent in the population.
- Widespread Prescription Practices: Oxycodone has been widely prescribed as an opioid medication, contributing to its growth within the broader opioid market.
- Regulatory Changes: While the market faces scrutiny due to concerns about misuse and addiction, regulatory interventions are also leading to changes in prescribing practices that may impact oxycodone’s availability and use.
Competitive Landscape
The global oxycodone market is highly fragmented as there are numerous notable players operating in the market. Key strategies that market players are using to gain an edge include:
- Investing in research and development: Market players are investing heavily in research and development to develop new and improved oxycodone products. This includes developing new formulations of oxycodone that are more difficult to abuse and new indications for oxycodone.
- Expanding product portfolio: Market players are also expanding their product portfolio by acquiring smaller companies or developing new products in-house. This allows them to offer a wider range of oxycodone products to meet the needs of different patients.
- Focusing on key markets: Market players are focusing their efforts on key markets, such as the United States and Europe. These markets are home to many potential patients and have high healthcare spending.
- Building relationships with key stakeholders: Market players are building relationships with key stakeholders, such as healthcare professionals, patients, and policymakers. This helps them to gain a better understanding of the needs of these stakeholders and to develop products and services that meet these needs.
In addition to the strategies mentioned above, oxycodone market players are also focusing on developing new delivery methods for oxycodone. For example, certain companies are developing oxycodone patches that can be applied to the skin, while others are developing oxycodone nasal sprays. These new delivery methods offer several advantages over traditional oral formulations of oxycodone, such as faster onset of action, improved pain relief, and reduced risk of abuse.
Recent Developments by Key Oxycodone Market Players:
- Teva Pharmaceutical Industries Ltd. got FDA approval for VANTRELATM ER extended-release tablets that were formulated with Teva’s proprietary abuse deterrence technology for managing daily severe pain. The product’s approval was supported by a clinical program to evaluate efficacy, safety, and abuse potential of VANTRELA ER.
- Purdue Pharma signed an agreement with United States Department of Justice to deliver more than US$ 10 billion in value opioid crisis to communities and claimants.
- Mylan and Pfizer collaborated under combination of Mylan and Upjohn to form Viatris. The company is expected to flourish into a sustainable healthcare journey by expanding medicine access and meeting patient needs.
Key Segments Covered in Oxycodone Market Study
By Oxycodone Type:
- Long-acting oxycodone
- Short-acting oxycodone
By Application:
- Pain Management
- De-addiction
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube